Increment of Skeletal Muscle Mass Predicts Survival Benefit for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Combining Molecular Targeted Agents and Immune Checkpoint Inhibitors

Increment of Skeletal Muscle Mass Predicts Survival Benefit for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Combining Molecular Targeted Agents and Immune Checkpoint Inhibitors

Wen Chen,1,* Hai-Tao Yan,1,* Jin-Xing Zhang,1 Xiao Shen,1 Jin Liu,2 Sheng Liu,1 Hai-Bin Shi,1 Ye Ding,3 Qing-Quan Zu1 1Department of Interventional Radiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, People’s Republic of China; 2Department of Cl...

Full description

Saved in:
Bibliographic Details
Main Authors: Chen W, Yan HT, Zhang JX, Shen X, Liu J, Liu S, Shi HB, Ding Y, Zu QQ
Format: Article
Language:English
Published: Dove Medical Press 2025-02-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
hepatocellular carcinoma
immune checkpoint inhibitors
molecular targeted therapy
sarcopenia
transarterial chemoembolization.
Online Access:https://www.dovepress.com/increment-of-skeletal-muscle-mass-predicts-survival-benefit-for-hepato-peer-reviewed-fulltext-article-JHC
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/increment-of-skeletal-muscle-mass-predicts-survival-benefit-for-hepato-peer-reviewed-fulltext-article-JHC

Similar Items